Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Drug targets in the cytokine universe for autoimmune disease.

Liu X, Fang L, Guo TB, Mei H, Zhang JZ.

Trends Immunol. 2013 Mar;34(3):120-8. doi: 10.1016/j.it.2012.10.003. Epub 2012 Oct 29. Review.

PMID:
23116550
2.

Immunocytokines: a novel class of products for the treatment of chronic inflammation and autoimmune conditions.

Bootz F, Neri D.

Drug Discov Today. 2016 Jan;21(1):180-189. doi: 10.1016/j.drudis.2015.10.012. Epub 2015 Oct 23. Review.

3.

Trends in the development of therapeutic anti-cytokine antibodies.

Reichert JM.

Drug Discov Today. 2004 Apr 15;9(8):348. No abstract available.

PMID:
15081960
4.

Autoimmune diseases in gastroenterology.

Emmrich J, Jaster R.

Curr Pharm Des. 2012;18(29):4542-5. Review.

PMID:
22612745
5.

[Anticytokine therapy].

Naumann L, Feist E, Burmester GR.

Internist (Berl). 2013 Apr;54(4):449-61; quiz 462-3. doi: 10.1007/s00108-012-3202-7. German.

PMID:
23463462
6.

The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.

Emmi L, Chiarini F.

Neurol Sci. 2002 Apr;23 Suppl 1:S1-8. Review.

PMID:
12032582
7.

Acting on the cytokine balance to control auto-immunity and chronic inflammation.

Miossec P.

Eur Cytokine Netw. 1993 Jul-Aug;4(4):245-51. Review. No abstract available.

PMID:
8268414
8.

Modern anti-cytokine therapy of autoimmune diseases.

Astrakhantseva IV, Efimov GA, Drutskaya MS, Kruglov AA, Nedospasov SA.

Biochemistry (Mosc). 2014 Dec;79(12):1308-21. doi: 10.1134/S0006297914120049. Review.

9.

[Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].

Szegedi G.

Orv Hetil. 2005 Apr 3;146(14):635-43. Review. Hungarian.

PMID:
15889537
10.

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

Williams RO, Paleolog E, Feldmann M.

Curr Opin Pharmacol. 2007 Aug;7(4):412-7. Epub 2007 Jul 12. Review.

PMID:
17627887
11.

[Targeted therapy in inflammatory disease: cytokines].

von Frenckell C, Malaise MG.

Rev Med Liege. 2012;67 Spec No:22-8. French.

PMID:
22690482
12.

[The current outlook in the therapy of autoimmune diseases].

Sebastiani GD, Passiu G.

Ann Ital Med Int. 1992 Apr-Jun;7(2):95-101. Review. Italian.

PMID:
1467130
13.

Setting the cytokine trap for autoimmunity.

Dinarello CA.

Nat Med. 2003 Jan;9(1):20-2. No abstract available.

PMID:
12514715
15.

Therapeutic benefits of regulating inflammation in autoimmunity.

Nikoopour E, Schwartz JA, Singh B.

Inflamm Allergy Drug Targets. 2008 Sep;7(3):203-10. Review.

PMID:
18782028
16.

Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.

Cvetkovic I, Stosic-Grujicic S.

Int Immunopharmacol. 2006 Oct;6(10):1527-34. Epub 2006 Jul 12. Review.

PMID:
16919824
17.

Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

Lai Y, Dong C.

Int Immunol. 2016 Apr;28(4):181-8. doi: 10.1093/intimm/dxv063. Epub 2015 Nov 6. Review.

18.

[Monoclonal antibodies in chronic autoimmune inflammatory diseases].

Semerano L, Boissier MC.

Med Sci (Paris). 2009 Dec;25(12):1108-12. doi: 10.1051/medsci/200925121108. Review. French.

19.

IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.

Leng RX, Pan HF, Tao JH, Ye DQ.

Expert Opin Ther Targets. 2011 Feb;15(2):119-26. doi: 10.1517/14728222.2011.534461. Epub 2010 Nov 12. Review.

PMID:
21073280
20.

5th annual conference on cytokines and inflammation 29-30 January 2007, Breckenridge, Colorado, USA.

Numerof RP, Blasko E.

Expert Opin Ther Targets. 2007 Jul;11(7):983-7.

PMID:
17614766

Supplemental Content

Support Center